Effect of octreotide on gastrointestinal motility in children with functional gastrointestinal symptoms

Journal of Pediatric Gastroenterology and Nutrition

Volumn 27, Issue 5, 1998, Pages 508-512

  Di Lorenzo, Carlo ^a   Lucanto, Cristina ^a   Flores, Alejandro F ^b   Idries, Shaheen ^c   Hyman, Paul E ^c  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b NEWTON WELLESLEY HOSPITAL   (United States)

^c University of Pittsburgh ^*

Author keywords

Functional bowel disorders; Gastrointestinal motility; Motor migrating complex; Octreotide

Indexed keywords

OCTREOTIDE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED STUDY; DIET RESTRICTION; DRUG EFFECT; DUODENUM; DYSPEPSIA; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASE; GASTROINTESTINAL MOTILITY; HUMAN; INTESTINE PSEUDOOBSTRUCTION; MALE; MYOPATHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOOTH MUSCLE CONTRACTION; STOMACH ANTRUM;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; GASTROINTESTINAL AGENTS; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MOTILITY; HUMANS; OCTREOTIDE;

EID: 0031723572     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-199811000-00002     Document Type: Article

References (31)

1. Peeters TL, Janssens J, Vantrappen GR. Somatostatin and the interdigestive migrating motor complex in man. Regul Pept 1983;5: 209-17.
2. Hyman PE, Napolitano JA, Diego A, et al. Antroduodenal manometry in the evaluation of chronic functional gastrointestinal symptoms. Pediatrics 1990;86:39-44.
3. Di Lorenzo C, Hyman PE, Flores AF, et al. Antroduodenal manometry in children and adults with severe nonulcer dyspepsia. Scand J Gastroenterol 1994;29:799-806.
4. Vantrappen G, Janssens J, Hellemans J, Ghoos Y. The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine. J Clin Invest 1977;59:1158-66.
5. Di Lorenzo C, Flores AF, Buie T, Hyman PE. Intestinal motility and jejunal feeding in children with chronic intestinal pseudo-obstruction. Gastroenterology 1995;108:1379-85.
6. Dooley CP, Di Lorenzo C, Valenzuela JE. Variability of migrating motor complex in humans. Dig Dis Sci 1992;37:723-8.
7. Moreau JP, DeFeudis FV. Minireview. Pharmacological studies of somatostatin and somatostatin-analogues: Therapeutic advances and perspectives. Life Sci 1987;40:419-37.
8. Gyr KE, Meier R. Pharmacodynamic effects of sandostatin in the gastrointestinal tract. Digestion 1993;54(suppl 1):14-9.
9. Gu ZF, Pradhan T, Coy DH, et al. Action of somatostatin on gastric smooth muscle cells. Am J Physiol 1992;262:G432-8.
10. Haruma K, Wiste JA, Camilleri M. Effect of octreotide on gastro-intestinal pressure profiles in health and in functional and organic gastrointestinal disorders. Gut 1994;35:1064-9.
11. Soudah HC, Hasler W, Owyang C. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N Engl J Med 1991;325:1461-7.
12. Tomomasa T, Di Lorenzo C, Morikawa A, Uc A, Hyman P. Analysis of fasting antroduodenal manometry in children. Dig Dis Sci 1996;41:2195-203.
13. Hyman PE, McDiarmid SV, Napolitano J, Abrams CE, Tomomasa T. Antroduodenal motility in children with chronic intestinal pseudo-obstruction. J Pediatr 1988;112:899-905.
14. Von der Ohe M, Leben J, Cherian L, Layer P. Synthetisches somatostatinanalogon octreotide: Wirkung auf interdigestive pankreassekretion und gastrointestinale motilitat beim menschen. Med Klin 1993;88:18-22.
15. Lamers CBHW, Bijlstra AM, Harris AG. Octreotide, a long-acting somatostatin analog, in the management of postoperative dumping syndrome. An update. Dig Dis Sci 1993;30:359-64.
16. Richards WO, Geer R, D'Orisio TM, et al. Octreotide acetate induces fasting small bowel motility in patients with dumping syndrome. J Surg Res 1990;49:483-7.
17. Lamberts SWJ, Van der Lely AJ, De Herder WW, Hofland LJ. Octreotide. N Engl J Med 1996;334:246-54.
18. von der Ohe MR, Camilleri M, Thomforde GM, Klee GG. Differential regional effects of octreotide on human gastrointestinal motor function. Gut 1995;36:743-8.
19. Hussaini SH, Pereira SP, Veysey MJ, et al. Roles of gallbladder emptying and intestinal transit in the pathogenesis of octreotide induced gallbladder stones. Gut 1996;38:775-83.
20. Petersen JM, Saltzman M, Sherwin RS, Lange R, McCallum RW. Somatostatin inhibits gastric emptying of solids and liquids in man (abstract). Dig Dis Sci 1984;29:A64.
21. Londong W, Angerer M, Kutz K, Landgraf R, Londong V. Diminishing efficacy of octreotide (SMS 201-995) on gastric functions of healthy subjects during one-week administration. Gastroenterology 1989;96:713-22.
22. Verne GN, Eaker EY, Hardy E, Sninsky CA. Effect of octreotide and erythromycin on idiopathic and scleroderma-associated intestinal pseudoobstruction. Dig Dis Sci 1995;40:1892-901.
23. Lanting PJ, Kruijsen MW, Rasher JJ, van den Hoogen FH, Boerbooms AM, van de Putte LB. Severe intestinal pseudoobstruction in a patient with systemic sclerosis. Successful treatment with octreotide [letter]. J Rheumatol 1993;20:2175.
24. Hostein J, Janssens J, Vantrappen G, Peeters TL, Vandeweerd M, Leman G. Somatostatin induces ectopic activity fronts of the migrating motor complex via a local intestinal mechanism. Gastroenterology 1994;87:1004-8.
25. Nelson-Piercy C, Hammond PJ, Gwilliam ME, et al. Effect of a new oral somatostatin analog (SDZ CO 611) on gastric emptying, mouth to cecum transit time, and pancreatic and gut hormone release in normal male subjects. J Clin Endocrinol Metab 1994; 78:329-36.
26. Janssens J, Vantrappen G, Peeters TL. The activity front of the migrating motor complex of the human stomach but not of the small intestine is motilin-dependent. Regul Pept 1983;6:363-9.
27. Idries S, Di Lorenzo C, Flores AF, Hyman PE. The effect of sequential erythromycin and octreotide on antroduodenal motility (abstract). Gastroenterology 1995;108:A619.
28. Fox-Threlkeld JET. Motility and regulatory peptides. In: Kumar D, Wingate D, eds. An illustrated guide to gastrointestinal motility. New York: Churchill Livingstone, 1993:78-92.
29. Peeters TL, Romanski KW, Janssens J, Vantrappen G. Effect of the long-acting somatostatin analogue SMS 201-995 on small-intestinal interdigestive motility in the dog. Scand J Gastroenterol 1988;23:769-74.
30. Lembcke B, Creutzfeldt W, Schleser S, Ebert R, Shaw C, Koop I. Effect of the somatostatin (SMS 201-995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men. Digestion 1987;36:108-24.
31. Fuessl HS, Carolan G, Williams G, Bloom SR. Effect of a long-acting somatostatin analogue (SMS 201-995) on postprandial gastric emptying of 99mTc-Tin colloid and mouth-to-caecum transit time in man. Digestion 1987;36:101-7.